These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17467100)

  • 1. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes.
    Terada T; Mizobata M; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2007 Jun; 119(3):262-70. PubMed ID: 17467100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells.
    Terada T; Mizobata M; Kawakami S; Yabe Y; Yamashita F; Hashida M
    J Drug Target; 2006 Sep; 14(8):536-45. PubMed ID: 17050120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells.
    Cai L; Qiu N; Li X; Luo K; Chen X; Yang L; He G; Wei Y; Chen L
    Int J Pharm; 2011 Apr; 408(1-2):173-82. PubMed ID: 21277964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
    Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
    J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of surface charge and density of distearylphosphatidylethanolamine-mPEG-2000 (DSPE-mPEG-2000) on the cytotoxicity of liposome-entrapped ricin: effect of lysosomotropic agents.
    Rathore SS; Ghosh PC
    Int J Pharm; 2008 Feb; 350(1-2):79-94. PubMed ID: 17913409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
    Terada T; Iwai M; Kawakami S; Yamashita F; Hashida M
    J Control Release; 2006 Apr; 111(3):333-42. PubMed ID: 16488046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and antitumor activity of bFGF-mediated active targeting doxorubicin microbubbles.
    Wu Y; Lu CT; Li WF; Sun CZ; Yang W; Zhang Y; Su ZX; Zhang Y; Fu HX; Huang PT; Lv HF; Dai DD; Li X; Lin GY; Luo SM; Zhao YZ
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1712-9. PubMed ID: 23062067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
    Hong M; Zhu S; Jiang Y; Tang G; Pei Y
    J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D; Garg A; Kokkoli E
    Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.
    Francavilla C; Loeffler S; Piccini D; Kren A; Christofori G; Cavallaro U
    J Cell Sci; 2007 Dec; 120(Pt 24):4388-94. PubMed ID: 18042627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.
    Huang Z; Ye C; Liu Z; Wang X; Chen H; Liu Y; Tang L; Zhao H; Wang J; Feng W; Li X
    Bioconjug Chem; 2012 Apr; 23(4):740-50. PubMed ID: 22433083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
    Udayakumar TS; Nagle RB; Bowden GT
    Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
    Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the protective effects of truncated bFGF and native bFGF against murine lung carcinoma.
    Luo Z; Peng X; Shi H; Gong C; Qian Z; Yang L
    Int J Mol Med; 2011 Jul; 28(1):3-8. PubMed ID: 21503566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.
    Shmeeda H; Tzemach D; Mak L; Gabizon A
    J Control Release; 2009 Jun; 136(2):155-60. PubMed ID: 19331844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.